Lucid dreaming with galantamine

What is lucid dreaming?

Lucid dreaming is a state of consciousness in which you are aware that you are dreaming. During lucid dreaming you can take control of your dream and do things like flying or go on adventures in exotic places.

What is galantamine?

Galantamine is an alkaloid that was isolated, amongst other plants, from the bulbs and flowers of Galanthus caucasicus or the Caucausian snowdrop.

Galantamine is an acetylcholinesterase inhibitor which means that it will increase the concentration of aceylcholine, a neurotransmitter, in the brain by preventing it from breaking down.

What are the effects?

A study from 2018 shows that galantamine combined with the technique of mnemonic induction of lucid dreams were much more successful in inducing lucid dreaming when using galantamine

The percentage of participants who reported a lucid dream was significantly increased for both 4 mg (27%, odds ratio = 2.29) and 8 mg doses (42%, odds ratio = 4.46) compared to the active placebo procedure (14%). Galantamine also significantly increased dream recall, sensory vividness and complexity (p<0.05). Dream recall, cognitive clarity, control, positive emotion, vividness and self-reflection were increased during lucid compared to non-lucid dreams (p<0.0001). These results show that galantamine increases the frequency of lucid dreams in a dose-related manner. Furthermore, the integrated method of taking galantamine in the last third of the night with at least 30 minutes of sleep interruption and with an appropriately focused mental set is one of the most effective methods for inducing lucid dreams available today.

In other words, galantamine will significantly increase your ability to induce lucid dreaming. I know from personal experience that dreaming with galantamine is incredibly vivid and it is difficult to separate your dreams from reality while you are sleeping.

Citations

LaBerge, S., LaMarca, K., & Baird, B. (2018). Pre-sleep treatment with galantamine stimulates lucid dreaming: A double-blind, placebo-controlled, crossover study. PLoS ONE, 13(8). https://doi.org/10.1371/journal.pone.0201246

Leave a Reply

Your email address will not be published. Required fields are marked *